Hess, Brian
Townsend, William
Ai, Weiyun
Stathis, Anastasios
Solh, Melhem
Alderuccio, Juan Pablo
Ungar, David
Liao, Sam
Liao, Lori
Khouri, Lisa
Zhang, Xiaoyan
Boni, Joseph
Article History
Received: 26 July 2021
Accepted: 15 October 2021
First Online: 10 December 2021
Declarations
:
: B. Hess has had a consulting/advisory role for ADC Therapeutics, an advisory role for Bristol-Myers Squibb and AstraZeneca, and has served on the speaker’s bureau of AstraZeneca. W. Townsend has had a consulting/advisory role for Celgene, Gilead, and Roche; served on the speaker’s bureau of Celgene, Gilead, and Roche; received honoraria from Celgene, Gilead, Roche; received consulting fees from Celgene, Gilead, and Roche; received travel fees from Roche; and is supported by the National Institute for Health Research University College Hospitals Biomedical Research Centre. W. Ai has served on advisory boards for Acrotech Biopharma, ADC Therapeutics, BeiGene, Kymera Therapeutics, and Nurix Therapeutics, and received research funding from Nurix Therapeutics. A. Stathis has had a consulting role for Bayer, received research funding from AbbVie, ADC Therapeutics, Bayer, MEI Pharma, Merck, Novartis, Pfizer, and Roche, and fees for travel from AbbVie and PharmaMar. M. Solh received research funding from ADC Therapeutics and Partner Therapeutics, and served on advisory boards for Bristol-Myers Squibb, Pfizer, and Seattle Genetics, and on a speaker’s bureau for Amgen and Celgene. J.P. Alderuccio was paid for expert testimony by ADC Therapeutics, OncInfo, and OncLive, and he or his immediate family member has served on advisory boards for Agios Pharmaceuticals, Forma Therapeutics, Foundation Medicine, Inovio Pharmaceuticals, and Puma Biotechnology. D. Ungar and J. Boni are employees of ADC Therapeutics and own stock in the company. X. Zhang is a former employee of ADC Therapeutics. S. Liao, L. Liao, and L. Khouri are employees of Pharmax Research.